GMP synthesis of bulk drug substances. This IDIQ contract shall have a 5-year ordering period from march 14, 2025 through march 13, 2030.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95025D00003
- Awardee
-
Benuvia Operations, LLC UEI HY9DC6XAJFK3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $789,897 obligated
Award facts
- Opportunity
-
- GMP Synthesis of Bulk Drug Testing Pre-Solicitation · 75N95024R00058 · Posted Sep 1, 2023
- Combined order value
- $789,897 Current and potential, with all options
- Last date to order 32% complete
- IDV ceiling 8% used
- $10,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Davis-Bacon Act FAR subpart 22.4
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded an indefinite-delivery contract to Benuvia Operations, LLC on March 14, 2025, for Good Manufacturing Practice (GMP) synthesis of bulk drug substances, with a ceiling value of $10 million. This is a single-award IDIQ without set-aside designation.
The contract spans a five-year ordering period from March 14, 2025 through March 13, 2030. Work is performed in Round Rock, Texas.
The originating solicitation sought capability statements from small businesses capable of manufacturing both GMP and non-GMP bulk drug substances in large batch sizes, with onsite access to advanced analytical testing equipment including high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), isotope ratio (IR), circular dichroism (CD), and nuclear magnetic resonance (NMR). Offerors were required to demonstrate experience in preparing reports for FDA submissions and possession of DEA Research and Manufacturing Registrations for controlled substances.
Under this IDIQ, NIDA issued Task Order No. 75N95025F00001 on March 14, 2025, valued at $789,896.88 for GMP psilocybin synthesis. The order uses cost-plus-fixed-fee pricing and carries the same March 13, 2030 completion date.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| GMP synthesis of bulk drug substances. Task order no.75N95025F00001 (TO1), for synthesis of GMP psilocybin. | National Institute on Drug Abuse (NIH) | $789,897 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95025D00003?
75N95025D00003 was awarded to Benuvia Operations, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 14, 2025.
How much is contract 75N95025D00003 worth?
Orders under 75N95025D00003 have obligated $789,897. 75N95025D00003's own ceiling is $10,000,000.
How many orders have been placed under contract 75N95025D00003?
1 order has been placed under 75N95025D00003, the latest on March 14, 2025.
Who can order from contract 75N95025D00003?
75N95025D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95025D00003 competed?
The extent of competition for 75N95025D00003 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV